Ever Source Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 6,916 shares of BMRN stock, worth $366,202. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,916
Previous 1,437
381.28%
Holding current value
$366,202
Previous $101,000
276.24%
% of portfolio
0.02%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BMRN
# of Institutions
679Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.01 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$835 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$800 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$651 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.84B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...